stars 1 stars 2 stars 3

AdopTracell is an emerging preclinical stage company developing next-generation autoimmune therapies with the potential to profoundly improve patient outcomes. We are building a pipeline of targeted regulatory T-cell therapies, with a preliminary focus on Type 1 Diabetes.

Website https://www.adoptracell.com/
Employees 1 (0 on RocketReach)
Industry Biotechnology Research

adopTracell Questions

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users